Clinical Trial Update: An Exploratory Study Investigating Safety, Tolerability and Pharmacokinetics of Ascending Doses of Lu AE04621 in Parkinson Disease Patients [Phase 1]

View source ↗

Summary

Phase 1 exploratory study assessing safety, tolerability, and pharmacokinetics of ascending doses of Lu AE04621 in Parkinson disease patients; completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Lu AE04621

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED | Results posted: 2019-12-02